Clinical Chemistry and Laboratory Medicine (CCLM)
Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Editor-in-Chief: Plebani, Mario
Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R.
IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition
SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238
Considerations for the development of a reference method for sequencing of haploid DNA – an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics. International Federation of Clinical Chemistry and Laboratory Medicine
1Department of Medical Biology, Faculty of Medicine, Université Laval and CHUQ, Québec, Canada
2Directorate-General Research, European Commission, Brussels, Belgium
3European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Geel, Belgium
4Institute for Clinical Chemistry, Mannheim, Germany
5Department of Social and Preventative Medicine, Faculty of Medicine, Université Laval, Québec, Canada
6Biomedical Sciences and Curtin Health Innovation Research Institute, Curtin University of Technology, Perth, Australia
7Department of Clinical Chemistry, Erasmus MC, Rotterdam, The Netherlands
8University of Texas Southwestern, Dallas, USA
9Department of Clinical Chemistry, University of Florence, Florence, Italy
10Wellcome Research Laboratories, Belfast, UK
Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 47, Issue 11, Pages 1343–1350, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2009.319, October 2009
- Published Online:
Following the completion of sequencing of the human genome, there has been a very rapid increase in the development of new molecular diagnostic tests. However, the numerous genetic tests and genetic testing technologies offered do not always satisfy essential quality criteria required to ensure confidence in the results that are produced. This is of particular importance for genetic tests since many patients may be tested for a particular genetic defect only once in their lifetime. Thus, there is a pressing need for comprehensive guidelines for the validation of molecular diagnostic tests and procedures, including DNA sequencing, the latter being a fundamental aspect of the development and validation of most genetic tests. To that end, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee for Molecular Diagnostics has prepared the following paper that describes a possible approach to the development of a reference method for sequencing of haploid DNA. We discuss various aspects which should be considered before, during and after applying the sequencing procedure, in order to achieve results with a known level of confidence, including robustness and assessments of quality.
Clin Chem Lab Med 2009;47:1343–50.
Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.